This manuscript describing the phenotypes associated with loss and gain of RVCL-S documents important findings that have practical implications. Although the data and methods are solid and support ...
Insurance and health record data showed about 3% of smokers with peripheral artery disease were prescribed the smoking cessation drug, despite the significant benefits of quitting.
The University of Barcelona is consolidating its position at the forefront of European research thanks to the strategic ...
The current kidney care model—focused on late-stage disease and in-center hemodialysis—is unsustainable, because of costs, environmental burden, poor outcomes, and reduced quality of life.
Chronic kidney disease is a silent epidemic that is often diagnosed too late, leading to limited treatment options and poor outcomes, and the U.S. health care system needs to prioritize early ...
Chronic kidney disease is a silent epidemic that is often diagnosed too late, leading to limited treatment options and poor outcomes, and the U.S. health care system needs to prioritize early ...
Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the ...
Daniel Martínez-Pérez is investigating TSPO, a biomarker of neuroinflammation, and its role in the progression of Alzheimer's disease.
Alzheimer's disease researchers say they've built a method using simple blood tests to predict if and when someone may show ...
Researchers developed plasma p-tau217–based clock models that estimate when cognitively unimpaired individuals with Alzheimer’s pathology may develop symptomatic disease. The models predicted symptom ...
Carfilzomib prevented BCMA degradation, increased target density, and improved CAR T susceptibility by ~26%–28% in vitro, while enhancing xenograft antitumor activity without worsening T-cell ...
Predicting Parkinson's disease (PD) motor progression remains challenging despite advances in neuroimaging. Blood-based transcriptomic profiling offers a more accessible and cost-effective alternative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results